.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Fluoropyrimidines in Cancer Therapy
Youcef M. . Ed(S): Rustum
€ 203.77
FREE Delivery in Ireland
Description for Fluoropyrimidines in Cancer Therapy
hardcover. Reviews the mechanisms of action and the therapeutic selectivity and efficacy of 5-FU with and without leucovorin and its prodrugs in the treatment of colorectal cancer. This book considers combination agents such as UFT/LV, 5-FU/EU, capecitabine (Xeloda), S-1, and various thymidylate synthase inhibitors. Editor(s): Rustum, Youcef M. Series: Cancer Drug Discovery and Development. Num Pages: 326 pages, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 254 x 178 x 20. Weight in Grams: 807.
Leading cancer researchers update and review the mechanisms of action and the therapeutic selectivity and efficacy of 5-FU with and without leucovorin and its prodrugs in the treatment of colorectal cancer. Among the combination agents considered are UFT/LV, 5-FU/EU, capecitabine (Xeloda), S-1, and a variety of thymidylate synthase inhibitors. The authors discuss the potential advantages and disadvantages of these varied drugs and their mode of administration. Based on historical results with these agents when used alone, they also present a rationale for their results when used in combination with other agents.
Leading cancer researchers update and review the mechanisms of action and the therapeutic selectivity and efficacy of 5-FU with and without leucovorin and its prodrugs in the treatment of colorectal cancer. Among the combination agents considered are UFT/LV, 5-FU/EU, capecitabine (Xeloda), S-1, and a variety of thymidylate synthase inhibitors. The authors discuss the potential advantages and disadvantages of these varied drugs and their mode of administration. Based on historical results with these agents when used alone, they also present a rationale for their results when used in combination with other agents.
Product Details
Format
Hardback
Publication date
2002
Publisher
Humana United States
Number of pages
326
Condition
New
Series
Cancer Drug Discovery and Development
Number of Pages
326
Place of Publication
Totowa, NJ, United States
ISBN
9780896039568
SKU
V9780896039568
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Fluoropyrimidines in Cancer Therapy